Pancreatic cancer patients in Ukraine treated with Tumour Specific Electroporation™ (TSE) are continuing to improve
Scandinavian ChemoTech has received a new report from Ulis Hospital Ukraine, which states that the quality of life of the treated pancreatic cancer patients continues to improve in the fifth month of treatment. The team of specialists at Ulis Hospital in Ukraine have recently reported that the quality of life of the two pancreatic cancer patients treated with TSE in September 2022 continues to improve. These two unresectable locally advanced pancreatic cancer patients had both received TSE treatments in combination with a low dose of chemotherapy, using ChemoTech’s IQwave™ device.